Stercuronium iodide |
|
| Other names | MYC-1080; MYSC-1080 |
|---|
|
(3β)-N-Ethyl-N,N-dimethylcona-4,6-dienin-3-aminium iodide
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| CompTox Dashboard (EPA) | |
|---|
|
| Formula | C26H43IN2 |
|---|
| Molar mass | 510.548 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
CC[N+](C)(C)[C@H]1CC[C@@]2([C@H]3CC[C@]45CN([C@H]([C@H]4CC[C@H]5[C@@H]3C=CC2=C1)C)C)C.[I-]
|
InChI=1S/C26H43N2.HI/c1-7-28(5,6)20-12-14-25(3)19(16-20)8-9-21-23(25)13-15-26-17-27(4)18(2)22(26)10-11-24(21)26;/h8-9,16,18,20-24H,7,10-15,17H2,1-6H3;1H/q+1;/p-1/t18-,20-,21+,22+,23-,24-,25-,26-;/m0./s1 Key:NZMZXOUHSHDAQQ-VIGAWJBNSA-M
|
Stercuronium iodide (INN, USAN) (developmental code names MYC-1080, MYSC-1080) is an aminosteroid neuromuscular blocking agent which was never marketed.[1][2] It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR), and is also reported to be an acetylcholinesterase inhibitor.[1]
References
- ^ a b Kar A (2005). Medicinal Chemistry. New Age International. pp. 175–. ISBN 978-81-224-1565-0.
- ^ Bowden RE, Collier B, Dripps RD, Duchen LW, Enderby GE, Ginsborg BL, Head S, Hobbiger F, Jenkinson DM, MacIntosh, Smith SE (13 March 2013). Neuromuscular Junction. Springer Science & Business Media. pp. 421–. ISBN 978-3-642-45476-9.
|
|---|
Enzyme (modulators) | | ChATTooltip Choline acetyltransferase |
- Inhibitors: 1-(-Benzoylethyl)pyridinium
- 2-(α-Naphthoyl)ethyltrimethylammonium
- 3-Chloro-4-stillbazole
- 4-(1-Naphthylvinyl)pyridine
- Acetylseco hemicholinium-3
- Acryloylcholine
- AF64A
- B115
- BETA
- CM-54,903
- N,N-Dimethylaminoethylacrylate
- N,N-Dimethylaminoethylchloroacetate
|
|---|
| AChETooltip Acetylcholinesterase |
- Unsorted: α-Pinene
- α-Viniferin
- Affinine
- Affinisine
- Arisugacin A
- Bulbocapnine
- Conodurine
- Coronaridine
- Corydaline
- Corynoline
- Crimidine
- Cyclanoline
- Cymserine
- Harmaline
- Kobophenol A
- Lactucopicrin
- Lycorine
- Phosacetim
- Rosmarinic acid
- Taspine
- Tetrahydrocannabinol
- Ungeremine
- Ungiminorine
- Dimethylcarbamoyl fluoride
- BW284C51
- TMTFA
- 3152 CT
|
|---|
| BChETooltip Butyrylcholinesterase | |
|---|
|
|---|
Transporter (modulators) | | CHTTooltip Choline transporter | |
|---|
| VAChTTooltip Vesicular acetylcholine transporter | |
|---|
|
|---|
Release (modulators) | |
|---|
- See also
- Receptor/signaling modulators
- Muscarinic acetylcholine receptor modulators
- Nicotinic acetylcholine receptor modulators
|
|
|---|
| nAChRsTooltip Nicotinic acetylcholine receptors | Agonists (and PAMsTooltip positive allosteric modulators) |
- 5-HIAA
- 6-Chloronicotine
- A-84,543
- A-366,833
- A-582,941
- A-867,744
- ABT-202
- ABT-418
- ABT-560
- ABT-894
- Acetylcholine
- Altinicline
- Anabasine
- Anatabine
- Anatoxin-a
- AR-R17779
- Bephenium hydroxynaphthoate
- Butinoline
- Butyrylcholine
- Carbachol
- Choline
- Choline m-bromophenyl ether
- Cotinine
- Cytisine
- Decamethonium
- Desformylflustrabromine
- Dianicline
- Dimethylphenylpiperazinium
- Epibatidine
- Epiboxidine
- Ethanol (alcohol)
- Ethoxysebacylcholine
- EVP-4473
- EVP-6124
- Galantamine
- GTS-21
- Ispronicline
- Ivermectin
- JNJ-39393406
- Levamisole
- Lobeline
- MEM-63,908 (RG-3487)
- Morantel
- Nicotine (tobacco)
- NS-1738
- PHA-543,613
- PHA-709,829
- PNU-120,596
- PNU-282,987
- Pozanicline
- Pyrantel
- Rivanicline
- RJR-2429
- Sazetidine A
- SB-206553
- Sebacylcholine
- SIB-1508Y
- SIB-1553A
- SSR-180,711
- Suberyldicholine
- Suxamethonium (succinylcholine)
- Suxethonium (succinyldicholine)
- TC-1698
- TC-1734
- TC-1827
- TC-2216
- TC-5214
- TC-5619
- TC-6683
- Tebanicline
- Tribendimidine
- Tropisetron
- UB-165
- Varenicline
- WAY-317,538
- XY-4083
|
|---|
Antagonists (and NAMsTooltip negative allosteric modulators) | |
|---|
|
|---|
Precursors (and prodrugs) | |
|---|
- See also
- Receptor/signaling modulators
- Muscarinic acetylcholine receptor modulators
- Acetylcholine metabolism/transport modulators
|